2,4-thiazolidinedione has been researched along with Cardiovascular Stroke in 5 studies
thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.
Excerpt | Relevance | Reference |
---|---|---|
"Over a 20-year period, patients on dapagliflozin were projected to experience relative reductions in the incidence of myocardial infarction (MI), stroke, CV death, and all-cause death of 13." | 3.80 | Modeling effects of SGLT-2 inhibitor dapagliflozin treatment versus standard diabetes therapy on cardiovascular and microvascular outcomes. ( Alperin, P; Cohen, M; Dziuba, J; Goswami, D; Grossman, HL; Hardy, E; Iloeje, U; Perlstein, I; Racketa, J, 2014) |
"The patients were those with type 2 diabetes mellitus hospitalized with a first MI and the controls were those with diabetes mellitus randomly selected from the same geographic area." | 1.33 | Insulin sensitizing pharmacotherapy for prevention of myocardial infarction in patients with diabetes mellitus. ( Berlin, JA; Cappola, AR; Kimmel, SE; Sauer, WH, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dziuba, J | 1 |
Alperin, P | 1 |
Racketa, J | 1 |
Iloeje, U | 1 |
Goswami, D | 1 |
Hardy, E | 1 |
Perlstein, I | 1 |
Grossman, HL | 1 |
Cohen, M | 1 |
Koro, CE | 1 |
Fu, Q | 1 |
Stender, M | 1 |
Frye, RL | 1 |
August, P | 1 |
Brooks, MM | 1 |
Hardison, RM | 1 |
Kelsey, SF | 1 |
MacGregor, JM | 1 |
Orchard, TJ | 1 |
Chaitman, BR | 1 |
Genuth, SM | 1 |
Goldberg, SH | 1 |
Hlatky, MA | 1 |
Jones, TL | 1 |
Molitch, ME | 1 |
Nesto, RW | 1 |
Sako, EY | 1 |
Sobel, BE | 1 |
Störk, S | 1 |
Ertl, G | 1 |
Nitschmann, S | 1 |
Sauer, WH | 1 |
Cappola, AR | 1 |
Berlin, JA | 1 |
Kimmel, SE | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes[NCT00006305] | Phase 3 | 2,368 participants (Actual) | Interventional | 2000-09-30 | Completed | ||
Allopurinol in the Treatment of Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Treated by Either PCI or CABG: Pilot Study[NCT03700645] | Phase 4 | 100 participants (Anticipated) | Interventional | 2018-12-01 | Not yet recruiting | ||
Effect of Modifying Anti-platelet Treatment to Ticagrelor in Patients With Diabetes and Low Response to Clopidogrel[NCT01643031] | Phase 4 | 500 participants (Anticipated) | Interventional | 2012-08-31 | Not yet recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
(NCT00006305)
Timeframe: five years
Intervention | participants (Number) |
---|---|
Revascularization and Insulin Providing (IP) | 80 |
Revascularization and Insulin Sensitizing (IS) | 75 |
Medical Therapy and Insulin Providing (IP) | 80 |
Medical Therapy and Insulin Sensitizing (IS) | 81 |
(NCT00006305)
Timeframe: five years
Intervention | participants (Number) |
---|---|
Revascularization and Insulin Providing (IP) | 145 |
Revascularization and Insulin Sensitizing (IS) | 121 |
Medical Therapy and Insulin Providing (IP) | 143 |
Medical Therapy and Insulin Sensitizing (IS) | 140 |
1 trial available for 2,4-thiazolidinedione and Cardiovascular Stroke
Article | Year |
---|---|
A randomized trial of therapies for type 2 diabetes and coronary artery disease.
Topics: Angioplasty, Balloon, Coronary; Combined Modality Therapy; Coronary Angiography; Coronary Artery Byp | 2009 |
A randomized trial of therapies for type 2 diabetes and coronary artery disease.
Topics: Angioplasty, Balloon, Coronary; Combined Modality Therapy; Coronary Angiography; Coronary Artery Byp | 2009 |
A randomized trial of therapies for type 2 diabetes and coronary artery disease.
Topics: Angioplasty, Balloon, Coronary; Combined Modality Therapy; Coronary Angiography; Coronary Artery Byp | 2009 |
A randomized trial of therapies for type 2 diabetes and coronary artery disease.
Topics: Angioplasty, Balloon, Coronary; Combined Modality Therapy; Coronary Angiography; Coronary Artery Byp | 2009 |
A randomized trial of therapies for type 2 diabetes and coronary artery disease.
Topics: Angioplasty, Balloon, Coronary; Combined Modality Therapy; Coronary Angiography; Coronary Artery Byp | 2009 |
A randomized trial of therapies for type 2 diabetes and coronary artery disease.
Topics: Angioplasty, Balloon, Coronary; Combined Modality Therapy; Coronary Angiography; Coronary Artery Byp | 2009 |
A randomized trial of therapies for type 2 diabetes and coronary artery disease.
Topics: Angioplasty, Balloon, Coronary; Combined Modality Therapy; Coronary Angiography; Coronary Artery Byp | 2009 |
A randomized trial of therapies for type 2 diabetes and coronary artery disease.
Topics: Angioplasty, Balloon, Coronary; Combined Modality Therapy; Coronary Angiography; Coronary Artery Byp | 2009 |
A randomized trial of therapies for type 2 diabetes and coronary artery disease.
Topics: Angioplasty, Balloon, Coronary; Combined Modality Therapy; Coronary Angiography; Coronary Artery Byp | 2009 |
4 other studies available for 2,4-thiazolidinedione and Cardiovascular Stroke
Article | Year |
---|---|
Modeling effects of SGLT-2 inhibitor dapagliflozin treatment versus standard diabetes therapy on cardiovascular and microvascular outcomes.
Topics: Amputation, Surgical; Benzhydryl Compounds; Blood Glucose; Blood Pressure; Body Weight; Cardiovascul | 2014 |
An assessment of the effect of thiazolidinedione exposure on the risk of myocardial infarction in type 2 diabetic patients.
Topics: Adult; Aged; Case-Control Studies; Cohort Studies; Databases, Factual; Diabetes Mellitus, Type 2; Fe | 2008 |
[Revascularization in patients with type 2 diabetes and coronary artery disease: BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) Study Group].
Topics: Angioplasty, Balloon, Coronary; Combined Modality Therapy; Coronary Angiography; Coronary Artery Byp | 2010 |
Insulin sensitizing pharmacotherapy for prevention of myocardial infarction in patients with diabetes mellitus.
Topics: Adult; Aged; Case-Control Studies; Confounding Factors, Epidemiologic; Diabetes Mellitus, Type 2; Dr | 2006 |